In a challenging market environment, Atossa Genetics Inc . (NASDAQ:ATOS) stock has touched a 52-week low, reaching a price ...

Leerink Partners cut shares of Myriad Genetics from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $30.00 to $21.00 in a research ...

In a challenging year for the biotech sector, Fulgent Genetics Inc . (NASDAQ:FLGT) stock has touched a 52-week low, dipping ...

In this article, we are going to take a look at where Myriad Genetics, Inc. (NASDAQ:MYGN) stands against Larry Robbins’ other long-term stock picks. Larry Robbins is an American hedge fund ...

In a challenging year for the biotech sector, Fulgent Genetics Inc . (NASDAQ:FLGT) stock has touched a 52-week low, dipping to $16.54. The company, known for its comprehensive... In a recent ...

The company is focused on developing, producing and distributing genetic tests utilized in the oncology and women's and pharmacogenomic fields. The stock currently trades just north of $13.00 and ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

Investing.com - Sophia Genetics (NASDAQ: SOPH) reported first quarter EPS of $-0.17, $0.17 better than the analyst estimate of $-0.34. Revenue for the quarter came in at $13.4M ...

The firm owned 55,315 shares of the company’s stock after selling 23,296 shares during the quarter. Fifth Third Bancorp owned 0.06% of Myriad Genetics worth $758,000 as of its most recent filing ...